The FT’s Daniel Garrahan presents a 60-second update on the day’s headlines from FirstFT, including Greece’s hopes to extend its bailout, Apple’s virtual reality ambitions and a big day for Argentina. For more video content from the Financial Times, visit … Continue reading →

MIT Tech Review reports, In a small trial in Rwanda, a $34 smartphone attachment rapidly and accurately detected the presence of HIV and syphilis antibodies in drops of blood taken from pregnant women. The work, described in a paper published … Continue reading →

Good stuff. It is difficult to put a true value on a stock without being influenced by its price. Aswath Damodaran, professor of finance at NYU Stern Business School, tells John Authers that movements in Apple’s price and valuation create … Continue reading →

Take a look at the relative growth of Qualcomm‘s market cap, revenues, and earnings since 2005 as presented at the company’s annual meeting last month. No bubble in the stock price here. The big question is: has the massive … Continue reading →

Back in January 2011 we posted the following about Apple: It’s our sense that in five years Apple may well have reinvented itself into a mobile medical company, where an iPhone/iPad-type device becomes a medical clinic in, say, a rural … Continue reading →